Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial 4B-15-11
A Phase II Trial of sEphB4-HSA in Combination with Anti PD1 Antibody (Pembrolizumab, MK-3475) for Solid Tumors
Type:
Treatment
Phase:
Phase II
Status:
Open to Accrual
Treatments:
Immunotherapy
Randomized:
No
USC Satellite Location:
USC Koreatown, USC Newport Beach Oncology
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Sarmad Sadeghi, M.D.
Other Trial Staff:
Cheryl Kefauver, Coordinator, Lagrimas Ilagan, D.M., Charis Barg, Coordinator, Bartolo Santos, Coordinator, Bomi Choi, Coordinator
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.